Similarly, pathogenic germline variants in BRCA1 and BRCA2 were detected in 6 (0.34%) and 16 (0.79%) participants, respectively, in another study which involved 1764 Chinese lung cancer patients.13 This evidence concerns the gene BRCA2 and lung cancer.